Cervical cancer, 95% linked to HPV, causes 350,000 deaths yearly. The outdated speculum leads 45% of women under 35 to skip screenings due to fear, especially affecting ethnic minorities.
A self-sampling kit for HPV-based cervical screening. It uses patent-pending bio-tech and menstrual blood for simplified lab testing. Our technology can also be expanded to other STI testing in the future.
A start-up from Imperial College London's WeInnovate Programme. With years of research and development, our team developed a paper-based solution powered by overlooked menstrual blood.
